Nuova Proteins Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.00 M
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.47 Cr
- Satisfied Charges ₹ 2.83 Cr
- Revenue Growth %
- Profit Growth -170.33%
- Ebitda -184.39%
- Net Worth -9.26%
- Total Assets -15.75%
About Nuova Proteins
Company Details
-
Location
Karnal, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15122HR2007PTC036986
-
Company No.
036986
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jun 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Nuova Proteins?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ranbir Raman
![]() |
Director | 28-Jun-2007 | Current |
Dinesh Arya
![]() |
Director | 28-Jun-2007 | Current |
Financial Performance of Nuova Proteins.
Nuova Proteins Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 170.33% decrease in profit. The company's net worth dipped by a decrease of 9.26%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Nuova Proteins?
In 2023, Nuova Proteins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹14.65 M
₹28.30 M
Charges Breakdown by Lending Institutions
- Canara Bank : 1.47 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Dec 2016 | Canara Bank | ₹0.85 M | Open |
18 Mar 2016 | Canara Bank | ₹1.33 Cr | Open |
06 Mar 2014 | Canara Bank | ₹0.50 M | Open |
23 May 2008 | Canara Bank | ₹2.83 Cr | Satisfied |
How Many Employees Work at Nuova Proteins?
Unlock and access historical data on people associated with Nuova Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Nuova Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuova Proteins's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.